<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03470025</url>
  </required_header>
  <id_info>
    <org_study_id>22/17</org_study_id>
    <nct_id>NCT03470025</nct_id>
  </id_info>
  <brief_title>Improving Psychosocial Well-being in COPD Patients in Rehabilitation</brief_title>
  <acronym>IMPROVE</acronym>
  <official_title>Psychological Intervention to Improve the COPD Patients' Psychosocial Well-being</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS San Raffaele</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Because of a lack of clinical trials, there is currently a paucity of evidence on the most
      effective strategies to identify and address psychological co-morbidity in COPD, or on
      targeting these interventions to specific patient groups. The relationship between
      physiological disease impairment and patient's disease experience is weak. Some patients have
      highly impaired Quality of life (QoL) despite relatively minor lung function impairment, and
      others have good QoL despite severe lung function impairment. It is likely that psychological
      and behavioral factors may be relevant; moreover the coping strategies used by patients and
      their relationship to individual psychological factors have been incompletely explored.
      Pulmonary Rehabilitation (PR) is part of integrated COPD patient management and its potential
      impact on QoL should be underlined: several studies have found that physical exercise has a
      beneficial effect on depression symptoms [GOLD, 2017].

      Before initiating PR a comprehensive and careful assessment should be performed: treatment
      goals, specific healthcare needs, smoking status, nutritional health, self-management
      capacity, health educational, psychological health status and social circumstances, medical
      history and comorbidities, and exercise capabilities and limitations. Moreover, PR has
      beneficial effects on mood status and daily activities.

      Sustaining Pulmonary Rehabilitation benefits and regular exercise over the long term is
      difficult without any maintenance strategy. The main aim of this study is to assess the
      Effect of the Psychological Intervention (PI) on Quality of life, psychological status and
      well-being, and the maintenance of Pulmonary Rehabilitation benefits, in COPD patients.

      A PI based on psychoeducation and psychological and emotional support may be a key to improve
      Quality of life and to bring COPD patients to show a greater awareness of their health
      status.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this pilot study we will perform two different methodologies of the Psychological
      Intervention: a telephone-based Psychological Intervention and combined face to face &amp;
      telephone-based Psychological Intervention, integrating the COPD rehabilitation.

      The study will be carried out in a real life setting. An initial sample of 36 COPD patients
      satisfying the inclusion criteria and accepting the participation of the study will be
      enrolled at the PR Unit of the IRCCS &quot;San Raffaele Pisana&quot; Roma-Italy. The study enrollment
      period will be of maximum six months, the treatment period is of six months, and the interim
      treatment evaluation is of three months will be performed. Max study duration will be of 12
      months.

      The participants will be recruited prospectively from consecutively admitted patients to the
      inpatient PR Unit. Participants will be required to have the diagnosis of COPD according to
      the ATS' Guideline [Qaseem et al., 2011]. All participants will sign informed consent
      approved by the Institutional Ethic Committee.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 10, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Health related Quality of Life evaluated by the St. George's Respiratory Questionnaire</measure>
    <time_frame>day 0 to day 182</time_frame>
    <description>the St. George's Respiratory Questionnaire score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Quality of Life evaluated by the Short Form Health Survey General and Mental Health</measure>
    <time_frame>day 0 to day 182</time_frame>
    <description>the Short Form Health Survey General and Mental Health score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in the degree of enjoyment and satisfaction in areas of daily functioning, evaluated by the Quality Of Life Enjoyment And Satisfaction Questionnaire</measure>
    <time_frame>day 0 to day 182</time_frame>
    <description>the Quality Of Life Enjoyment And Satisfaction Questionnaire score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maintenance of Functional Exercise evaluated by the Six Minute Walking Test</measure>
    <time_frame>day 0 to day 182</time_frame>
    <description>the Six Minute Walking Test score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maintenance of Respiratory Capacity evaluated by the Borg scale</measure>
    <time_frame>day 0 to day 182</time_frame>
    <description>the Borg scale score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of dyspnea in activities of daily living by the Medical Research Council scale</measure>
    <time_frame>day 0 to day 21 (period of the Pulmonary Rehabilitation )</time_frame>
    <description>the Medical Research Council score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of Respiratory Capacity by the Maugeri Foundation Respiratory Failure Questionnaire</measure>
    <time_frame>day 0 to day 21 (period of the Pulmonary Rehabilitation)</time_frame>
    <description>the Maugeri Foundation Respiratory Failure score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of disability by the Barthel Index</measure>
    <time_frame>day 0 to day 21 (period of the Pulmonary Rehabilitation )</time_frame>
    <description>Barthel Index score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in psychological status evaluated by the Symptom Check List (SCL-90)</measure>
    <time_frame>day 0 to day 182</time_frame>
    <description>the SCL-90 scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of the severity of depression by the Beck Depression Inventory II</measure>
    <time_frame>day 0 to day 182</time_frame>
    <description>the Beck Depression Inventory score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of different types of anxiety, state anxiety and trait anxiety, by State-Trait Anxiety Inventory Form Y.</measure>
    <time_frame>day 0 to day 182</time_frame>
    <description>the State-Trait Anxiety Inventory scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the use of the Coping Strategies evaluated by Brief-COPE</measure>
    <time_frame>day 0 to day 182</time_frame>
    <description>Brief-COPE</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>Psychological Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A weekly combined face to face &amp; telephone-based PI (F-TPI); Psychological Intervention and medical therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A telephone-based PI (TPI)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Psychological Intervention - A telephone-based PI (TPI); Psychological Intervention and medical therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Optimal medical therapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will receive optimal medical therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Psychological Intervention</intervention_name>
    <description>F-TPI group will be followed for a period of six months with a telephone-based and a face to face psychological intervention, performed by a clinical psychotherapist .
TPI group will be followed for a period of six months with a TPI characterized by 10 telephone clinical interviews, performed by a clinical psychotherapist.
CTRL group with COPD SoC without PI will follow the standard follow-up program for COPD patients after PR.</description>
    <arm_group_label>Psychological Intervention</arm_group_label>
    <arm_group_label>A telephone-based PI (TPI)</arm_group_label>
    <other_name>Medical therapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of COPD

          -  Mini-Mental State Examination (MMSE) ≥ 26

          -  6 Minute Walking Test ≥ 90 meters , at admission

          -  Obtaining Written Informed Consent

        Exclusion Criteria:

          -  Comorbidity influencing respiratory ability and functionality

          -  Delta 6 Minute Walking Distance &lt; 60 meters, at time of admission
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giulia Prinzi, MA</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS San Raffaele Pisana</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Giulia Prinzi, MA</last_name>
    <phone>00390652253409</phone>
    <email>giulia.prinzi@sanraffaele.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>IRCCS San Raffaele Pisana</name>
      <address>
        <city>Roma</city>
        <zip>I-00163</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giulia Prinzi, MA</last_name>
      <phone>00390652253409</phone>
      <email>giulia.prinzi@sanraffaele.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med. 1997;4(1):92-100.</citation>
    <PMID>16250744</PMID>
  </reference>
  <reference>
    <citation>Celli B, Tetzlaff K, Criner G, Polkey MI, Sciurba F, Casaburi R, Tal-Singer R, Kawata A, Merrill D, Rennard S; COPD Biomarker Qualification Consortium. The 6-Minute-Walk Distance Test as a Chronic Obstructive Pulmonary Disease Stratification Tool. Insights from the COPD Biomarker Qualification Consortium. Am J Respir Crit Care Med. 2016 Dec 15;194(12):1483-1493.</citation>
    <PMID>27332504</PMID>
  </reference>
  <reference>
    <citation>Chen Q, Wu C, Gao Y, Chen L, Liu Y. A clinical study on the role of psychosomatic therapy in evaluation and treatment of patients with chronic obstructive pulmonary disease complicated with anxiety-depression disorder. Int J Clin Exp Med. 2015 Sep 15;8(9):16613-9. eCollection 2015.</citation>
    <PMID>26629192</PMID>
  </reference>
  <reference>
    <citation>Graydon JE, Ross E. Influence of symptoms, lung function, mood, and social support on level of functioning of patients with COPD. Res Nurs Health. 1995 Dec;18(6):525-33.</citation>
    <PMID>7480853</PMID>
  </reference>
  <reference>
    <citation>Güell MR, Cejudo P, Ortega F, Puy MC, Rodríguez-Trigo G, Pijoan JI, Martinez-Indart L, Gorostiza A, Bdeir K, Celli B, Galdiz JB. Benefits of Long-Term Pulmonary Rehabilitation Maintenance Program in Patients with Severe Chronic Obstructive Pulmonary Disease. Three-Year Follow-up. Am J Respir Crit Care Med. 2017 Mar 1;195(5):622-629. doi: 10.1164/rccm.201603-0602OC.</citation>
    <PMID>27611807</PMID>
  </reference>
  <reference>
    <citation>Healy K. A Theory of Human Motivation by Abraham H. Maslow - reflection. Br J Psychiatry. 2016 Apr;208(4):313. doi: 10.1192/bjp.bp.115.179622.</citation>
    <PMID>27036694</PMID>
  </reference>
  <reference>
    <citation>Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, McCormack MC, Carlin BW, Sciurba FC, Pitta F, Wanger J, MacIntyre N, Kaminsky DA, Culver BH, Revill SM, Hernandes NA, Andrianopoulos V, Camillo CA, Mitchell KE, Lee AL, Hill CJ, Singh SJ. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014 Dec;44(6):1428-46. doi: 10.1183/09031936.00150314. Epub 2014 Oct 30. Review.</citation>
    <PMID>25359355</PMID>
  </reference>
  <reference>
    <citation>Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992 Jun;145(6):1321-7.</citation>
    <PMID>1595997</PMID>
  </reference>
  <reference>
    <citation>Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP, Stanley MA. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005 Apr;127(4):1205-11.</citation>
    <PMID>15821196</PMID>
  </reference>
  <reference>
    <citation>Lazarus RS. Coping theory and research: past, present, and future. Psychosom Med. 1993 May-Jun;55(3):234-47. Review.</citation>
    <PMID>8346332</PMID>
  </reference>
  <reference>
    <citation>Martinez FD. Early-Life Origins of Chronic Obstructive Pulmonary Disease. N Engl J Med. 2016 Sep 1;375(9):871-8. doi: 10.1056/NEJMra1603287. Review.</citation>
    <PMID>27579637</PMID>
  </reference>
  <reference>
    <citation>Martinu T, Babyak MA, O'Connell CF, Carney RM, Trulock EP, Davis RD, Blumenthal JA, Palmer SM; INSPIRE Investigators. Baseline 6-min walk distance predicts survival in lung transplant candidates. Am J Transplant. 2008 Jul;8(7):1498-505. doi: 10.1111/j.1600-6143.2008.02264.x.</citation>
    <PMID>18510641</PMID>
  </reference>
  <reference>
    <citation>Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, Hanania NA; ACCP Workshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008 Oct;134(4 Suppl):43S-56S. doi: 10.1378/chest.08-0342. Review.</citation>
    <PMID>18842932</PMID>
  </reference>
  <reference>
    <citation>Perret JL, Walters EH, Abramson MJ, McDonald CF, Dharmage SC. The independent and combined effects of lifetime smoke exposures and asthma as they relate to COPD. Expert Rev Respir Med. 2014 Aug;8(4):503-14. doi: 10.1586/17476348.2014.905913. Epub 2014 May 16. Review.</citation>
    <PMID>24834459</PMID>
  </reference>
  <reference>
    <citation>Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schünemann H, Wedzicha W, MacDonald R, Shekelle P; American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011 Aug 2;155(3):179-91. doi: 10.7326/0003-4819-155-3-201108020-00008.</citation>
    <PMID>21810710</PMID>
  </reference>
  <reference>
    <citation>Russo P, Prinzi G, Kisialiou A, Cardaci V, Stirpe E, Conti V, Fini M, Bonassi S. Action plans and coping strategies in elderly COPD patients influence the result of pulmonary rehabilitation: an observational study. Eur J Phys Rehabil Med. 2017 Apr 14. doi: 10.23736/S1973-9087.17.04501-4. [Epub ahead of print]</citation>
    <PMID>28417609</PMID>
  </reference>
  <reference>
    <citation>Smoller JW, Pollack MH, Otto MW, Rosenbaum JF, Kradin RL. Panic anxiety, dyspnea, and respiratory disease. Theoretical and clinical considerations. Am J Respir Crit Care Med. 1996 Jul;154(1):6-17. Review.</citation>
    <PMID>8680700</PMID>
  </reference>
  <reference>
    <citation>Usmani ZA, Carson KV, Heslop K, Esterman AJ, De Soyza A, Smith BJ. Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017 Mar 21;3:CD010673. doi: 10.1002/14651858.CD010673.pub2. Review.</citation>
    <PMID>28322440</PMID>
  </reference>
  <reference>
    <citation>van Manen JG, Bindels PJ, Dekker FW, IJzermans CJ, van der Zee JS, Schadé E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax. 2002 May;57(5):412-6.</citation>
    <PMID>11978917</PMID>
  </reference>
  <reference>
    <citation>Vanfleteren LEGW, Spruit MA, Wouters EFM, Franssen FME. Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respir Med. 2016 Nov;4(11):911-924. doi: 10.1016/S2213-2600(16)00097-7. Epub 2016 Jun 2. Review.</citation>
    <PMID>27264777</PMID>
  </reference>
  <reference>
    <citation>Vögele C, von Leupoldt A. Mental disorders in chronic obstructive pulmonary disease (COPD). Respir Med. 2008 May;102(5):764-73. doi: 10.1016/j.rmed.2007.12.006. Epub 2008 Jan 28.</citation>
    <PMID>18222685</PMID>
  </reference>
  <reference>
    <citation>Woodruff PG, Agusti A, Roche N, Singh D, Martinez FJ. Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management. Lancet. 2015 May 2;385(9979):1789-1798. doi: 10.1016/S0140-6736(15)60693-6. Review.</citation>
    <PMID>25943943</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2018</study_first_submitted>
  <study_first_submitted_qc>March 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2018</study_first_posted>
  <last_update_submitted>March 16, 2018</last_update_submitted>
  <last_update_submitted_qc>March 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS San Raffaele</investigator_affiliation>
    <investigator_full_name>Giulia Prinzi</investigator_full_name>
    <investigator_title>Researcher</investigator_title>
  </responsible_party>
  <keyword>Rehabilitation</keyword>
  <keyword>Psychological Intervention</keyword>
  <keyword>Quality of life</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

